AIM–Bio Project: An international collaborative addressing the future needs of the biopharmaceutical industry

The AIM-Bio Program brings together two academic universities, NC State and the Technical University of Denmark (DTU), with complementary areas of expertise to create an international collaboration to drive innovation in research and education in manufacturing biopharmaceuticals. Funded by the Novo Nordisk Foundation, this six-year US$27 million program will support the biopharmaceutical industry in both Denmark and the United States.

AIM-Bio will benefit society by developing new technologies to reduce the cost and increase the effectiveness, safety and accessibility of new biopharmaceutical products. The program will also establish a lasting bond for international collaboration between NC State University and the Technical University of Denmark.

We invite you to explore the AIM-Bio website to learn more about the program and opportunities for students, academic researchers and industry professionals to participate in research, professional development courses, networking and much more.

Dr. Ruben G. Carbonell

Review the research on topics that range from cell factory engineering to upstream bioreactor design and optimization.

Learn more about new courses being developed for industry professionals on topics that are particularly relevant to the future.

Explore how this ambitious research and workforce development program is engaging in international exchange.

AIM-Bio Program Overview

World-Class Research

US$27 Million Grant

6-Year Project

A NC State and Technical University of Denmark Collaborative

NC State University and the Technical University of Denmark (DTU) are embarking on a 6-year program to advance biomanufacturing.